Alembic Pharmaceuticals Limited (NSE:APLLTD)

Alembic Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	159,403	130,370	182,755	193,575	97,564	145,771
Market Cap Growth	-14.81%	-28.66%	-5.59%	98.41%	-33.07%	-23.15%
Enterprise Value	171,680	143,795	192,124	200,785	104,548	151,109
Last Close Price	810.95	653.53	906.05	949.00	473.08	696.10

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	22.99	19.32	31.33	31.43	28.53	27.98
Forward PE	20.31	16.15	25.37	28.71	19.15	19.76
PS Ratio	2.05	1.78	2.74	3.11	1.73	2.75
PB Ratio	2.81	2.30	3.52	4.02	2.23	2.78
P/TBV Ratio	2.96	2.42	3.52	4.02	2.23	2.87
P/FCF Ratio	45.79	37.45	-	40.69	34.78	115.04
P/OCF Ratio	20.36	16.66	207.75	24.10	13.48	26.39
PEG Ratio	1.27	0.66	1.13	1.09	1.89	3.25

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.21	1.96	2.88	3.22	1.85	2.85
EV/EBITDA Ratio	14.88	13.10	19.42	21.97	15.02	17.60
EV/EBIT Ratio	20.82	18.04	26.33	30.39	23.88	25.72
EV/FCF Ratio	49.32	41.31	-	42.21	37.27	119.26

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.25	0.25	0.24	0.11	0.17	0.14
Debt / EBITDA Ratio	1.24	1.28	1.25	0.55	1.01	0.82
Debt / FCF Ratio	-	4.11	-	1.08	2.57	5.66
Net Debt / Equity Ratio	0.22	0.22	0.23	0.08	0.15	0.13
Net Debt / EBITDA Ratio	1.09	1.12	1.19	0.43	0.93	0.76
Net Debt / FCF Ratio	-	3.54	-2.47	0.83	2.31	5.18
Asset Turnover	-	0.89	0.94	0.99	0.85	0.77
Inventory Turnover	-	0.87	0.96	1.15	1.15	0.97
Quick Ratio	-	0.65	0.62	0.82	0.74	0.52
Current Ratio	-	1.76	1.70	2.12	1.78	1.67
Return on Equity (ROE)	-	12.36%	11.63%	13.40%	7.12%	10.11%
Return on Assets (ROA)	-	6.02%	6.42%	6.54%	4.11%	5.31%
Return on Invested Capital (ROIC)	11.34%	11.62%	10.38%	12.59%	7.74%	8.69%
Return on Capital Employed (ROCE)	-	12.90%	13.60%	13.20%	9.60%	10.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	4.35%	5.18%	3.19%	3.18%	3.50%	3.57%
FCF Yield	2.18%	2.67%	-2.60%	2.46%	2.88%	0.87%
Dividend Yield	1.49%	1.84%	1.21%	1.16%	1.69%	1.44%
Payout Ratio	-	32.04%	37.06%	25.54%	57.48%	52.83%
Buyback Yield / Dilution	-0.04%	-	-	-	-	-1.46%
Total Shareholder Return	1.45%	1.84%	1.21%	1.16%	1.69%	-0.02%

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error